Short course radiotherapy is an appropriate option for most malignant glioma patients

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 1, 1997, Pages 31-36

  Kleinberg, Lawrence R ^a   Slick, Tanya ^a   Enger, Cheryl ^a   Grossman, Stuart ^a   Brem, Henry ^a   Wharam Jr , Moody D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Anaplastic astrocytoma; Cost; Glioblastoma; Malignan glioma; Quality of life; Radiotherapy

Indexed keywords

ADULT; ARTICLE; BRAIN NECROSIS; CANCER DIAGNOSIS; CANCER STAGING; DOSE RESPONSE; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY;

BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; GLIOMA; HUMANS; MIDDLE AGED; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031127437     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00222-8     Document Type: Article

References (17)

1. 1. Bauman, G. S.; Gaspar, L. E.; Fisher, B. J.; Halperin, E. C.; MacDonald, D. R.; Cairncross, J. G. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 29:835-839; 1994.
2. 2. Chang, C. H.; Horton, J.; Schoenfeld, D.; Salazer, O.; Perez-Tamayo, R.; Kramer, S.; Weinstein, A.; Nelson, J. S.; Tsukada, Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:997-1007; 1983.
3. 3. Cox, D. R.; Oakes, D. Analysis of survival data. London: Chapman and Hall Ltd; 1984.
4. 4. Curran, W. J. Jr.; Scott, C. B.; Horton, J.; Nelson, J. S.; Weinstein, A. S.; Fischbach, A. J.; Chang, C. H.; Rotman, M.; Asbell, S. O.; Krisch, R. E.; Nelson, D. F. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. Natl. Cancer Inst. 85:704-710; 1993.
5. 5. Curran, W. J. Jr.; Scott, C. B.; Horton, J.; Nelson, J. S.; Weinstein, A. S.; Fischback, A. J.; Chang, C. H.; Rotman, M.; Asbell, S. O.; Krisch, R. E.; Nelson, D. F. A randomized trial of accelerated hyperfractionated radiation therapy and Bis-chloroethyl nitrosourea for malignant glioma: A preliminary report of Radiation Therapy Oncology Group 83-02. Cancer 70:2909-2917; 1992.
6. 6. Deutsch, M.; Green, S. B.; Strike, T. A.; Burger, P. C.; Robertson, J. T.; Selker, R. G.; Shapiro, W. R.; Mealey, J. Jr.; Ransohoff II, J.; Paoletti, P.; Smith, K. R. Jr.; Odom, G. L.; Hunt, W. E.; Young, B.; Alexander, E. Jr.; Walker, M. D.; Pistenmaa, D. A. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 16:1389-1396; 1989.
7. 7. Hernandez, J. C.; Maruyama, Y.; Yaes, R.; Chin, H. W. Accelerated fractionation radiotherapy for hospitalized glioblastoma multiforme patients with poor prognostic factors. J. Neurooncol. 9:41-45; 1990.
8. 8. Kaplan, E. L.; Meier, P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
9. 9. Marcial-Vega, V. A.; Wharam, M. D.; Leibel, S.; Clark, A.; Zweig, R.; Order, S. E. Treatment of supratentorial high grade gliomas with split course high fractional dose post-operative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 16:1419-1424; 1989.
10. 10. Marks, J. E.; Baglan, R. J.; Prassad, S. C.; et al. Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation, and volume. Int. J. Radiat. Oncol. Biol. Phys. 7:243-252; 1981.
11. 11. Nelson, D. F.; Diener-West, M.; Weinstein, A. S.; Schoenfeld, D.; Nelson, J. S.; Sause, W. T.; Chang, C. H.; Goodman, R.; Carabell, S. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: Final report of an RTOG study. Int. J. Radiat. Oncol. Biol. Phys. 12:1793-1800; 1986.
12. 12. Nelson, D. F.; Curran, W. J. Jr.; Scott, C. B.; Nelson, J. S.; Weinstein, A. S.; Khurshzo, A.; Constine, L. S.; Murray, K.; Powers, W. D.; Mohiuddin, M.; Fischbach, J. Hyperfractionated radiation therapy and Bis-chloroethyl nitrosourea in the treatment of malignant glioma: Possible advantage observed at 72.0 Gy in 1.2 Gy BID fractions: Report of RTOG protocol 83-02. Int. J. Radiat. Oncol. Biol. Phys. 25:193-207; 1993.
13. 13. Newall, J.; Ransohoff, J.; Kaplan, B. Glioblastoma in the older patient: How long a course of radiotherapy is necessary? J. Neurooncol. 6:325-327; 1988.
14. 14. Shapiro, W. R.; Green, S. B.; Burger, P. C.; Mahaley, M. S.; Selker, R. G.; VanGilder, J. C.; Robertson, J. T.; Ransohoff, J.; Mealey, J.; Strike, T. A.; Pistenmaa, D. A. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. J. Neurosurg. 71:1-9; 1989.
15. 15. Walker, M. D.; Alexander, E. Jr.; Hunt, W. E.; MacCarty, C. S.; Mahaley, M. S. Jr.; Mealey, J. J.; Norrell, H. A.; Owens, G.; Ransohoff, J.; Wilson, C. B.; Gehan, E. A.; Strike, T. A. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J. Neurosurg. 49:333-343; 1978.
16. 16. Walker, M. D.; Green, S. B.; Byar, D. P.; Alexander, E. Jr.; Batzdorf, U.; Brooks, W. H.; Hunt, W. E.; MacCarty, C. S.; Mahaley, M. S. Jr.; Mealey, J. Jr.; Owens, G.; Ransohoff, II, J.; Robertson, J. T.; Shapiro, W. R.; Smith, K. R. Jr.; Wilson, C. B.; Strike, T. A. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 303:1323-9; 1980.
17. 17. Weiss, H. Neoplasms. In Samuels, M. A., ed. Manual of neurologic therapeutics, 5th Ed. Boston, MA: Little, Brown, and Co, 1995.